These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32039847)

  • 1. Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
    Goldwaser EL; Acharya NK; Wu H; Godsey GA; Sarkar A; DeMarshall CA; Kosciuk MC; Nagele RG
    J Alzheimers Dis; 2020; 74(1):345-361. PubMed ID: 32039847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.
    Nagele RG; Clifford PM; Siu G; Levin EC; Acharya NK; Han M; Kosciuk MC; Venkataraman V; Zavareh S; Zarrabi S; Kinsler K; Thaker NG; Nagele EP; Dash J; Wang HY; Levitas A
    J Alzheimers Dis; 2011; 25(4):605-22. PubMed ID: 21483091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
    D'Andrea MR; Nagele RG
    Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    Acharya NK; Grossman HC; Clifford PM; Levin EC; Light KR; Choi H; Swanson Ii RL; Kosciuk MC; Venkataraman V; Libon DJ; Matzel LD; Nagele RG
    J Alzheimers Dis; 2024; 98(1):163-186. PubMed ID: 38393907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
    Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
    Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Aβ
    Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V
    Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons.
    Yang WN; Ma KG; Qian YH; Zhang JS; Feng GF; Shi LL; Zhang ZC; Liu ZH
    Int J Biochem Cell Biol; 2015 Jul; 64():252-64. PubMed ID: 25936756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
    Nagele RG; D'Andrea MR; Anderson WJ; Wang HY
    Neuroscience; 2002; 110(2):199-211. PubMed ID: 11958863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level.
    Deng J; Liu B; Tao Q; Luo Y; Zhu Y; Huang X; Yue F
    Neuroscience; 2024 May; 547():37-55. PubMed ID: 38604526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.
    Omtri RS; Davidson MW; Arumugam B; Poduslo JF; Kandimalla KK
    Mol Pharm; 2012 Jul; 9(7):1887-97. PubMed ID: 22574751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology.
    Wang HY; Lee DH; D'Andrea MR; Peterson PA; Shank RP; Reitz AB
    J Biol Chem; 2000 Feb; 275(8):5626-32. PubMed ID: 10681545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.
    Eimer WA; Vassar R
    Mol Neurodegener; 2013 Jan; 8():2. PubMed ID: 23316765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib.
    Acharya NK; Levin EC; Clifford PM; Han M; Tourtellotte R; Chamberlain D; Pollaro M; Coretti NJ; Kosciuk MC; Nagele EP; Demarshall C; Freeman T; Shi Y; Guan C; Macphee CH; Wilensky RL; Nagele RG
    J Alzheimers Dis; 2013; 35(1):179-98. PubMed ID: 23388174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.
    Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK
    Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
    Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
    Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain.
    Ma KG; Lv J; Yang WN; Chang KW; Hu XD; Shi LL; Zhai WY; Zong HF; Qian YH
    Brain Res Bull; 2018 Mar; 137():41-52. PubMed ID: 29128415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.
    Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG
    Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
    Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
    J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.